These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27790887)

  • 1. [Revision of fixed limits for drugs in the traffic].
    Strand MC; Innerdal C; Mathisrud G; Mørland J; Riedel B; Slørdal L; Aamo TO; Vindenes V
    Tidsskr Nor Laegeforen; 2016 Oct; 136(19):1619-1620. PubMed ID: 27790887
    [No Abstract]   [Full Text] [Related]  

  • 2. International trends in alcohol and drug use among vehicle drivers.
    Christophersen AS; Mørland J; Stewart K; Gjerde H
    Forensic Sci Rev; 2016 Jan; 28(1):37-66. PubMed ID: 26841722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugged Drivers Blood Concentrations in England and Wales Prior to the Introduction of Per Se Limits.
    Rooney B; Gouveia GJ; Isles N; Lawrence L; Brodie T; Grahovac Z; Chamberlain M; Trotter G
    J Anal Toxicol; 2017 Mar; 41(2):140-145. PubMed ID: 27798073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Driving Under the Influence of Drugs: Looking for Reasonable Blood Cutoffs and Realistic Analytical Values.
    Busardò FP; Pichini S; Pacifici R
    Clin Chem; 2017 Mar; 63(3):781-783. PubMed ID: 28087582
    [No Abstract]   [Full Text] [Related]  

  • 5. A better understanding of the interpretation of postmortem blood drug concentrations.
    Apple FS
    J Anal Toxicol; 2011 Jul; 35(6):381-3. PubMed ID: 21740697
    [No Abstract]   [Full Text] [Related]  

  • 6. Mortality among subjects previously apprehended for driving under the influence of traffic-hazardous medicinal drugs.
    Hausken AM; Skurtveit S; Christophersen AS
    Drug Alcohol Depend; 2005 Sep; 79(3):423-9. PubMed ID: 16102382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of safety margins for whole blood concentrations of alcohol and nineteen drugs in driving under the influence cases.
    Kristoffersen L; Strand DH; Liane VH; Vindenes V; Tvete IF; Aldrin M
    Forensic Sci Int; 2016 Feb; 259():119-26. PubMed ID: 26773222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANNOTATION TAKEN, IN THE PERSPECTIVE OF CRIMINAL AND CONSTITUTIONAL LAW, AS WELL AS IN CRIMINOLOGY, TO THE DECISION OF THE PORTUGUESE CONSTITUTIONAL COURT, OF JANUARY 13, 2011--WITH RESPECT TO THE PROBLEMS OF "CONSENT" AND "MEDICAL ACT".
    Bandeira GS
    Med Law; 2014 Jul; 33(2):57-90. PubMed ID: 27359009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentrations of scheduled prescription drugs in blood of impaired drivers: considerations for interpreting the results.
    Jones AW; Holmgren A; Kugelberg FC
    Ther Drug Monit; 2007 Apr; 29(2):248-60. PubMed ID: 17417081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Not Available].
    Augsburger M; Favrat B
    Praxis (Bern 1994); 2016 Nov; 105(24):1421-1425. PubMed ID: 27911656
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of Expanding ELISA Screening in DUID Investigations to Include Carisoprodol/Meprobamate and Zolpidem.
    Lu A; Scott KS; Chan-Hosokawa A; Logan BK
    J Anal Toxicol; 2017 Mar; 41(2):134-139. PubMed ID: 27798072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of drugs and alcohol found in road traffic fatalities: a comparative study of victims.
    Elliott S; Woolacott H; Braithwaite R
    Sci Justice; 2009 Mar; 49(1):19-23. PubMed ID: 19418924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of driving with blood drug concentrations above proposed new legal limits in Norway: estimations based on drug concentrations in oral fluid.
    Gjerde H; Normann PT; Christophersen AS; Mørland J
    Forensic Sci Int; 2011 Jul; 210(1-3):221-7. PubMed ID: 21482055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roadside drug testing: comparison of two legal approaches in Belgium.
    Van der Linden T; Wille SM; Ramírez-Fernandez M; Verstraete AG; Samyn N
    Forensic Sci Int; 2015 Apr; 249():148-55. PubMed ID: 25700110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency of drugs among Danish drivers before and after the introduction of fixed concentration limits.
    Steentoft A; Simonsen KW; Linnet K
    Traffic Inj Prev; 2010 Aug; 11(4):329-33. PubMed ID: 20730679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hair drug testing in the new Brazilian regulation to obtain professional driver's licence: no parallel to any other law enforcement in the world.
    Leyton V; Andreuccetti G; de Almeida RM; Muñoz DR; Walls HC; Greve JM; da Costa Montal JH; Adura FE; Yonamine M
    Addiction; 2015 Jul; 110(7):1207-8. PubMed ID: 25967396
    [No Abstract]   [Full Text] [Related]  

  • 17. Pupil function as an indicator of being under the influence of central nervous system-acting substances from a traffic-medicine perspective - Part II.
    Monticelli F; Preiss U; Hitzl W; Keller T
    Med Sci Law; 2016 Jan; 56(1):19-25. PubMed ID: 25899463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment based legislative limits for driving under the influence of non-alcohol drugs in Norway.
    Vindenes V; Jordbru D; Knapskog AB; Kvan E; Mathisrud G; Slørdal L; Mørland J
    Forensic Sci Int; 2012 Jun; 219(1-3):1-11. PubMed ID: 22118917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-MS/MS techniques for high-volume screening of drugs of abuse and target drug quantitation in urine/blood matrices.
    Eichhorst JC; Etter ML; Hall PL; Lehotay DC
    Methods Mol Biol; 2012; 902():29-41. PubMed ID: 22767105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical testing of impaired drivers.
    Sohn D; Simon J; Sohn S
    Leg Med Annu; 1974; 0(0):149-57. PubMed ID: 4461862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.